+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
DNA topoisomerase I inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

DNA topoisomerase I inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
CXCR4 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

CXCR4 receptor antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2024 - Product Thumbnail Image

FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
Advanced Non-Squamous & Squamous NSCLC - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Non-Squamous & Squamous NSCLC - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
From
From
Refractory Metastatic Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Metastatic Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Natural Killer T Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Natural Killer T Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Refractory Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
CAR T-Cell Therapy for Non-Hodgkin's lymphoma- - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-Cell Therapy for Non-Hodgkin's lymphoma- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Lymphatic Malformations- - Pipeline Insight, 2024 - Product Thumbnail Image

Lymphatic Malformations- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Inter Alpha Inhibitor Proteins - Pipeline Insight, 2024 - Product Thumbnail Image

Inter Alpha Inhibitor Proteins - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more